Chemistry: molecular biology and microbiology – Micro-organism – tissue cell culture or enzyme using process... – Recombinant dna technique included in method of making a...
Patent
1994-02-16
1997-05-06
Walsh, Stephen G.
Chemistry: molecular biology and microbiology
Micro-organism, tissue cell culture or enzyme using process...
Recombinant dna technique included in method of making a...
435 697, 4353201, 435368, 435354, 435325, 536 234, 536 235, 536 241, C12N 1585, C12N 1562, C12N 1510
Patent
active
056270470
ABSTRACT:
Three unique control DNA sequences of the glial fibrillary acidic (gfa) protein gene have been identified upstream of its basal promoter that are capable of regulating astrocyte-specific transcription of the human gene for glial fibrillary acidic protein (GFAP). One or more of those three regions alone or together with the SV40 early promoter and SV40 enhancer control expression of endogenous or heterologous protein in astrocytes. Transgenic animals expressing amyloid protein can be prepared and used as a model for evaluating Alzheimer's disease. Many heterologous proteins can be expressed in the astrocytes so as to take advantage of the growing list of astrocyte functions. Such proteins include hormones, growth factors, and their receptors. Examples include basic fibroblast growth factor (bFGF), acidic FGF (aFGF), platelet derived growth factor (PDGF), insulin like growth factors 1 and 2 (IGF-1, IGF-2), epidermal growth factor (EGF), transforming growth factors .beta.-1 and .beta.-2 (TGF.beta.1, TGF.beta.2), and S100.beta.; other examples totalled proteins encoded by oncogenes like myc, fos, and erb-a, ion channels, like the calcium channel and the potassium channel, and metabolic enzymes, especially ones involved in processing drugs or neurotransmitters; e.g., glutamine synthetase. Additionally, in each case, a dominant dysfunctional protein, an antisense RNA, or a ribozyme, all of which can inhibit the function or production of the protein, can be expressed in astrocytes.
REFERENCES:
patent: 4736866 (1988-04-01), Leder et al.
patent: 5387742 (1995-02-01), Cordell
Brenner, M. et al., Mol. Brain Res. 7 :277-286, 1990.
Nakatani, Y. et al., J. Cell. Biochem., Suppl. 14B, p. 212, Abstract E556, an. 27-Feb. 8, 1990.
Nakahira, K. et al., Cell Struct Funct, 16 (6):575, Abstract 1 D-1415, 1991. (Japan, Nov. 21-23, 1991).
Nakatani, Y. et al., Nature, 348 :86-88, 1990 (Nov.).
Brownell, E. et al., Genomics, 10 : 1087-1089, 1991 (Aug.).
Bongcam-Rudloff, E. et al., Cancer Research, 51 :1553-1560, 1991 (March).
Reeves, S. A. et al., PNAS, 86 :5178-82, 1989.
Proc. Nat'l Acad. Sci. USA, vol. 87, Yoshihiro Nakatani et al.; pp. 4289-4293; Jun. 1990.
EMBO Journal; vol. 10, No. 2; Dana O. Wirak et al.; pp. 289-296; 1991.
J. of Neuroscience Research 28: (1991); "Identification of a cis-Acting Positive Regulatory Element of the Glial Fibrillary Acidic Protein Gene"; pp. 217-228.
J. of Neurochem.; (1991); "Intragenic Sequences Affect the Expression of the Gene Encoding Glial Fibrillary Acidic Protein" pp. 675-684.
Cell-Specific Expression of the Mouse Glial Fibrillary Acidic Protein Gene: Identification of the Cis-and Trans-Acting Promoter Elements for Astrocyte-Specific Expression; Masayuki Miura et al.; pp. 1180-1188.
The New Biologist; vol. 3; No. 5; May 1991; "Rapid Activation of Astrocyte-Specific Expression of GFAP-lacZ Transgene by Focal Injury"; pp. 465-474.
Besnard Francois
Brenner Michael
Nakatani Yoshihiro
United States of America Department of Health and Human Services
Walsh Stephen G.
LandOfFree
Astrocyte-specific transcription of human genes does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Astrocyte-specific transcription of human genes, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Astrocyte-specific transcription of human genes will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-2131856